SPOTLIGHT: Medtronic wins FDA approval for Concerto

With potential device failure very much in the public eye after last year's recalls, it seems logical that technology which allows doctors to remotely keep tabs on how pacemakers and defibrillators are performing would be popular. That's probably good news for Medtronic: The company won FDA approval for its Concerto/Virtuoso line of implantable defibrillators, which allow wireless data transfer from the devices via patient home monitoring units. Article

Post a comment